285 related articles for article (PubMed ID: 18273899)
21. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
22. Silencer elements as possible inhibitors of pseudoexon splicing.
Sironi M; Menozzi G; Riva L; Cagliani R; Comi GP; Bresolin N; Giorda R; Pozzoli U
Nucleic Acids Res; 2004; 32(5):1783-91. PubMed ID: 15034146
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of human acatalasemia. Identification of a splicing mutation.
Wen JK; Osumi T; Hashimoto T; Ogata M
J Mol Biol; 1990 Jan; 211(2):383-93. PubMed ID: 2308162
[TBL] [Abstract][Full Text] [Related]
24. Purine-rich exon sequences are not necessarily splicing enhancer sequence in the dystrophin gene.
Ito T; Takeshima Y; Sakamoto H; Nakamura H; Matsuo M
Kobe J Med Sci; 2001 Oct; 47(5):193-202. PubMed ID: 11781497
[TBL] [Abstract][Full Text] [Related]
25. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing.
Anczuków O; Buisson M; Salles MJ; Triboulet S; Longy M; Lidereau R; Sinilnikova OM; Mazoyer S
Genes Chromosomes Cancer; 2008 May; 47(5):418-26. PubMed ID: 18273839
[TBL] [Abstract][Full Text] [Related]
26. The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA; McDonnell J; Marsh DJ
J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
[TBL] [Abstract][Full Text] [Related]
27. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein.
Imbard A; Boutron A; Vequaud C; Zater M; de Lonlay P; de Baulny HO; Barnerias C; Miné M; Marsac C; Saudubray JM; Brivet M
Mol Genet Metab; 2011 Dec; 104(4):507-16. PubMed ID: 21914562
[TBL] [Abstract][Full Text] [Related]
29. Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy.
De Meirleir L; Lissens W; Benelli C; Ponsot G; Desguerre I; Marsac C; Rodriguez D; Saudubray JM; Poggi F; Liebaers I
Pediatr Res; 1994 Dec; 36(6):707-12. PubMed ID: 7898978
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of the murine pyruvate dehydrogenase (Pdha1) gene and its effect on early embryonic development.
Johnson MT; Mahmood S; Hyatt SL; Yang HS; Soloway PD; Hanson RW; Patel MS
Mol Genet Metab; 2001 Nov; 74(3):293-302. PubMed ID: 11708858
[TBL] [Abstract][Full Text] [Related]
31. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
32. In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.
Fujihara N; Yamauchi K; Hirota-Kawadobora M; Ishikawa S; Tozuka M; Ishii E; Katsuyama T; Okumura N; Taniguchi S
Ann Clin Biochem; 2007 Nov; 44(Pt 6):573-8. PubMed ID: 17961316
[TBL] [Abstract][Full Text] [Related]
33. Identification of a splicing enhancer in MLH1 using COMPARE, a new assay for determination of relative RNA splicing efficiencies.
Xu DQ; Mattox W
Hum Mol Genet; 2006 Jan; 15(2):329-36. PubMed ID: 16357104
[TBL] [Abstract][Full Text] [Related]
34. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.
Pagani F; Buratti E; Stuani C; Baralle FE
J Biol Chem; 2003 Jul; 278(29):26580-8. PubMed ID: 12732620
[TBL] [Abstract][Full Text] [Related]
35. Mutational study in the PDHA1 gene of 40 patients suspected of pyruvate dehydrogenase complex deficiency.
Quintana E; Gort L; Busquets C; Navarro-Sastre A; Lissens W; Moliner S; Lluch M; Vilaseca MA; De Meirleir L; Ribes A; Briones P;
Clin Genet; 2010 May; 77(5):474-82. PubMed ID: 20002461
[TBL] [Abstract][Full Text] [Related]
36. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
Yang C; Romaniuk PJ
Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
[TBL] [Abstract][Full Text] [Related]
37. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity.
Nornes S; Newman M; Verdile G; Wells S; Stoick-Cooper CL; Tucker B; Frederich-Sleptsova I; Martins R; Lardelli M
Hum Mol Genet; 2008 Feb; 17(3):402-12. PubMed ID: 17981814
[TBL] [Abstract][Full Text] [Related]
38. Splicing error in E1alpha pyruvate dehydrogenase mRNA caused by novel intronic mutation responsible for lactic acidosis and mental retardation.
Miné M; Brivet M; Touati G; Grabowski P; Abitbol M; Marsac C
J Biol Chem; 2003 Apr; 278(14):11768-72. PubMed ID: 12551913
[TBL] [Abstract][Full Text] [Related]
39. Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points.
Wang J; Tse SW; Andreadis A
J Neurochem; 2007 Jan; 100(2):437-45. PubMed ID: 17144905
[TBL] [Abstract][Full Text] [Related]
40. [Pre-mRNA splicing: a source of a diversified gene expression network].
Mayeda A; Suzuki H
Tanpakushitsu Kakusan Koso; 2003 Mar; 48(4 Suppl):404-13. PubMed ID: 12696148
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
